MedTrace Logo

Measurement of Kidney Blood Flow and Oxygen Levels by MRI

NCT01318967 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-09-07

Study results available
· View outcomes & findings →

Summary

Comparison of renal blood flow measurements by PAH clearance and MRI

Conditions

Interventions

DRUG

Furosemide

Renal blood flow is measured after the administration of 20 mg of furosemide during MRI scan only.

OTHER

Placebo

Sponsors & Collaborators

  • Wake Forest University

    lead OTHER

Principal Investigators

  • Michael Rocco, MD · Wake Forest University Health Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-06-30
Completion
2013-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01318967 on ClinicalTrials.gov